Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Sector Update: Energy

Sector Update: Energy

MT newswireMT newswire2026/09/29 19:35
03:35 PM EDT, 09/29/2026 (MT Newswires) -- Energy stocks fell late Tuesday afternoon, with the NYSE Energy Sector Index declining 1.3% and the State Street Energy Select Sector SPDR ETF (XLE) shedding 0.9%. The Philadelphia Oil Service Sector Index dropped 2.3%, and the Dow Jones US Utilities Index added 1.2%. West Texas Intermediate crude oil fell 3.6% to $89.27 a barrel, and global benchmark Brent shed 2.5% to $102.66 a barrel. Henry Hub natural gas futures lost 2.8% to $3.02 per 1 million BTU. In corporate news, Uranium Energy (UEC) reported a fiscal Q4 net loss Tuesday of $0.12 per diluted share, compared with a loss of $0.06 a year earlier. Analysts polled by FactSet expected a loss of $0.04. Sales and service revenue for the quarter ended July 31 was $17.1 million. A single analyst expected $9 million. The company's shares were fractionally lower.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Why did the Reserve Bank of Australia raise interest rates two weeks ago? Meeting minutes reveal inflation risks have become a reality, and waiting would be too costly

The Reserve Bank of Australia acknowledges that the trade-off between inflation and full employment has worsened, but maintains that its goal is to return the Consumer Price Index (CPI) to the 2-3% target range.

智通财经•2026/10/13 02:41

Three-year remission rate up to 94%! Johnson & Johnson (JNJ.US) Tremfya Crohn's disease study shows positive long-term results

Long-term data from two Phase 3 clinical trials by Johnson & Johnson show that adult Crohn's disease patients treated with Tremfya (guselkumab) achieved a clinical remission rate of up to 94% over three years.

智通财经•2026/10/13 01:56